创伤性脑损伤后信号熵的动态评估用于预后判断与继发性脑损伤检测
该研究基于脑物理数据库 232 份创伤性脑损伤(TBI)患者的动脉血压与颅内压连续记录,用多尺度熵(MSE)在连续重叠的 6 小时片段中反复计算熵值。多变量分析及倾向性评分匹配校正 ICP、CPP 和压力反应性指数后,MSE abp 与 MSE cpp 低于阈值的时间百分比(OR 1.28(1.07-1.58)和 OR 1.50(1.16-2.03))及剂量(OR 1.12(1.02-1.27)和 OR 1.21(1.06-1.46))均与不良结局相关。MSE 轨迹随结局不同而显著不同,熵指标与临床参数仅弱相关,单次生理紊乱发作与脑源及体源生物信号 MSE 下降相关。作者认为熵的动态评估可辅助个体化、动态的预后判断与继发性脑损伤识别。
要点
- TBI 患者 MSE abp 低于阈值的时间百分比升高与不良结局相关(OR 1.28(1.07-1.58)),MSE cpp 相应 OR 1.50(1.16-2.03)。
- MSE abp 剂量升高与不良结局相关(OR 1.12(1.02-1.27)),MSE cpp 剂量 OR 1.21(1.06-1.46)。
- 上述关联在倾向性评分匹配后、校正 ICP、CPP 和压力反应性指数的多变量模型中仍存在。
- MSE 轨迹随 6 个月结局不同而显著不同,熵指标与临床参数仅呈弱相关。
- 单次生理紊乱发作(ICP、CPP 或压力反应性偏离)与脑源和体源生物信号 MSE 下降相关。
适用人群与场景
- 脑物理数据库中具备临床信息和 6 个月格拉斯哥结局量表(Glasgow Outcome Scale)的创伤性脑损伤(TBI)患者,共 232 份动脉血压与颅内压连续记录。
诊断标准与关键阈值
- 多尺度熵(MSE)从 0.1 Hz 起经 20 个粗粒化步骤聚合多个时间尺度的熵值,对连续重叠的 6 小时片段反复计算。
- 以低于不同界值的时间百分比(ptime)或剂量(持续时间×水平/小时)作为熵指标评估结局。
研究设计与关键结果
- 研究类型为基于脑物理数据库的连续记录分析,共 232 份 TBI 患者动脉血压与颅内压记录,结局为 6 个月格拉斯哥结局量表。
- MSE abp 低于界值的时间百分比升高与不良结局相关(OR 1.28(1.07-1.58)),MSE cpp 时间百分比升高与不良结局相关(OR 1.50(1.16-2.03))。
- MSE abp 剂量升高与不良结局相关(OR 1.12(1.02-1.27)),MSE cpp 剂量升高与不良结局相关(OR 1.21(1.06-1.46))。
- 上述关联在倾向性评分匹配后、校正 ICP、CPP 和压力反应性指数的多变量模型中仍存在。
- MSE 轨迹随结局不同而显著不同;熵指标与临床参数仅呈弱相关。
- 单次生理紊乱发作(ICP、CPP 或压力反应性偏离)与脑源和体源生物信号的 MSE 指标下降相关。
证据类型、等级与局限
- 证据类型:基于脑物理数据库的连续记录分析(观察性研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对生物信号熵动态变化的评估可辅助个体化、动态的预后判断和继发性脑损伤识别。
- 作者认为,这些探索有助于进一步利用重症监护环境中为每例 TBI 患者采集的大量生理数据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Entropy quantifies the level of disorder within a system. Low entropy reflects increased rigidity of homeostatic feedback systems possibly reflecting failure of protective physiological mechanisms like cerebral autoregulation. In traumatic brain injury (TBI), low entropy of heart rate and intracranial pressure (ICP) predict unfavorable outcome. Based on the hypothesis that entropy is a dynamically changing process, we explored the origin and value of entropy time trends.
METHODS: 232 continuous recordings of arterial blood pressure and ICP of TBI patients with available clinical information and 6-month outcome (Glasgow Outcome Scale) were accessed form the Brain Physics database. Biosignal entropy was estimated as multiscale entropy (MSE) that aggregates entropy at several time scales (20 coarse graining steps starting from 0.1 Hz). MSE was calculated repeatedly for consecutive, overlapping 6 h segments. Percentage monitoring time (ptime) or dosage (duration*level/hour) below different cutoffs were evaluated against outcome using univariable and multivariable analyses, and propensity score matching. Associations to clinical and monitoring metrics were explored using correlation coefficients. Lastly, individual secondary brain insults (deviations in ICP, cerebral perfusion pressure - CPP, or pressure reactivity) were assessed in relation to changes in MSE.
RESULTS: Increased MSE abp and MSE cpp ptime (OR 1.28 (1.07-1.58) and OR 1.50 (1.16-2.03) for MSE abp and cpp respectively) and dose (OR 1.12 (1.02-1.27) and OR 1.21 (1.06-1.46) for MSE abp and cpp respectively) were associated with poor outcome even after propensity score matching within multivariable models correcting for ICP, CPP, and the pressure reactivity index. MSE trajectories differed significantly dependent on outcome. The entropy metrics displayed weak correlations to clinical parameters. Individual episodes of deranged physiology were associated with decreases in the MSE metrics from both cerebral and systemic biosignals.
CONCLUSIONS: Biosignal entropy of changes dynamically after TBI. The assessment of these variations augments individualized, dynamic, outcome prognostication and identification of secondary cerebral insults. Additionally, these explorations allow for further exploitation of the extensive physiological data lakes acquired for each TBI patient within an intensive care environment.
参考来源
- Bögli SY, Olakorede I, Beqiri E, et al. Dynamic assessment of signal entropy for prognostication and secondary brain insult detection after traumatic brain injury. Crit Care. 2024. PMID: 39736677. doi:10.1186/s13054-024-05228-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。